Texas Capital Bancshares Inc/Tx (TCBIO) Liabilities and Shareholders Equity (2010 - 2026)

Texas Capital Bancshares (TCBIO) has reported Liabilities and Shareholders Equity for 17 consecutive years, with $33.9 billion the latest figure, recorded in Q2 2026.

• Quarterly Liabilities and Shareholders Equity rose 6.17% year-over-year to $33.9 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $131.5 billion (up 4.61% YoY) and the FY2025 annual result came in at $31.5 billion, up 2.63% from the prior year.
• Liabilities and Shareholders Equity grew to $33.9 billion in Q2 2026 per TCBIO's latest filing, from $33.5 billion in the prior quarter.
• Over the last five years, Liabilities and Shareholders Equity for TCBIO reached as high as $33.9 billion in Q2 2026 and fell as low as $28.4 billion in Q4 2023.
• A 5-year average of $30.8 billion and a median of $30.9 billion in 2022 frame the typical range for Liabilities and Shareholders Equity.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity fell 22.39% — and 2024, when it rose 8.38%.
• Year by year, Liabilities and Shareholders Equity stood at $28.4 billion in 2022, then fell by 0.21% to $28.4 billion in 2023, then advanced by 8.38% to $30.7 billion in 2024, then climbed by 2.63% to $31.5 billion in 2025, then climbed by 7.52% to $33.9 billion in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $33.9 billion, $33.5 billion, and $31.5 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.